• Interactions between commensal Enterococcus faecium and Enterococcus lactis and clinical isolates of Enterococcus faecium 

      Wagner, Theresa Maria; Pöntinen, Anna Kaarina; Fenzel, Carolin Kornelia; Engi, Daniel; Janice, Jessin; Almeida-Santos, Ana C.; Tedim, Ana P.; Freitas, Ana R.; Peixe, Luísa; van Schaik, Willem; Johannessen, Mona Susan; Hegstad, Kristin (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-03-09)
      Enterococcus faecium (Efm) is a versatile pathogen, responsible for multidrug-resistant infections, especially in hospitalized immuno compromised patients. Its population structure has been characterized by diverse clades (A1, A2, and B (reclassified as E. lactis (Ela)), adapted to different environments, and distinguished by their resistomes and virulomes. These features only partially explain ...
    • Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature 

      Bender, Jennifer; Cattoir, Vincent; Hegstad, Kristin; Sadowy, Eva; Coque, Teresa M.; Westh, Henrik; Hammerum, Anette M.; Schaffer, Kirsten; Burns, Karen; Murchan, Stephen; Novais, Carla; Freitas, Ana R.; Peixe, Luísa; Del Grosso, Maria; Pantosti, Annalisa; Werner, Guido (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-11-02)
      Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail. In vitro, most VRE remain susceptible to last-resort antibiotics such as linezolid, tigecycline and daptomycin. However, neither tigecycline nor linezolid act in a bactericidal manner, and ...